Home
About NCCTG
About Clinical Trials
NCCTG Trial Listings
Treatment Trials
Prevention/ Symptom Management Trials
Treating Locations
NCCTG News
Patient Advocacy
Biospecimen Access
Links
System
Institutional Members Only

Breast-Adjuvant Trial

The following NCCTG cancer treatment clinical trials are currently active. You may click on the trial number to link to a detailed description on PDQ, the National Cancer Institute's Web site for clinical trials.
BIG2-06 BIG 2-06/N063D, ALTTO: Adjuvant Lapatinib and/or Trastuzumab Treatment Optimisation Study - A randomised, multi-centre, open label, phase III study of adjuvant lapatinib, trastuzumab, their sequence and their combination in patients with HER2/ErbB2 positive primary breast cancer

For more information, please discuss these trials with your physician, contact the NCCTG Operations Office or contact an NCCTG treating location near you.


Return to list of Cancer Treatment Trials



© Copyright 2011, NCCTG